Literature DB >> 2403192

Illicit anabolic steroid use in athletes. A case series analysis.

P J Perry1, K H Andersen, W R Yates.   

Abstract

Because of recent anabolic steroid abuse scandals at all levels of athletic competition ranging from high school sports to the 1988 Olympics in Seoul, Korea, the investigators closely examined the anabolic steroid use histories of 20 competitive and noncompetitive weight lifters. Steroid efficacy studies only examine the anabolic effects of individual drugs. However, these 20 steroid users consistently practiced polypharmacy. During steroid use cycles lasting between 7 and 14 weeks, athletes commonly used two or three oral agents and two long-acting injectable products. Dosages of oral preparations tended to be similar to those used in efficacy studies, whereas dosages of the long-acting injectable agents were approximately three to eight times greater than those used in controlled studies. Subjects reported significant increases in body weight and strength. In addition, mental status changes were reported that included symptoms of depression, hostility, aggression, and paranoia. Based on the pattern of anabolic steroid use currently being practiced in the United States, it is apparent that past efficacy and toxicology studies are of limited value in delineating the benefits and hazards of these drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403192     DOI: 10.1177/036354659001800416

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  23 in total

1.  Patients with multiple sclerosis enter lottery.

Authors:  Gail McBride
Journal:  BMJ       Date:  1993-10-16

2.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 3.  Testosterone and doping control.

Authors:  C Saudan; N Baume; N Robinson; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

4.  Adolescent anabolic/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus).

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2013-10-11       Impact factor: 3.587

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

6.  Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters.

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2012-09-28       Impact factor: 3.587

Review 7.  Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1996-12       Impact factor: 11.136

Review 8.  Weight training. A potential confounding factor in examining the psychological and behavioural effects of anabolic-androgenic steroids.

Authors:  M S Bahrke; C E Yesalis
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

Review 9.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.